GNLX

What one share of Genelux holds

Pharmaceutical Preparations

Genelux’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Profit−$0.86
Capex (buildings and equipment)$0.08
Free cash flow−$0.70
Cash and investments$0.20
Book value$0.36

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2022—−$0.57$0.01−$0.40—−$3.92
2023$0.01−$1.16$0.04−$0.87—$0.73
2024$0.00−$0.95$0.01−$0.69—$0.76
2025$0.00−$0.86$0.03−$0.71—$0.30

Common questions about Genelux

How much does one share of Genelux earn?

Over the last 12 months, Genelux lost $0.86 for each share.

Does Genelux pay a dividend?

Genelux didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is Genelux’s book value per share?

Genelux’s book value is $0.36 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.

How much cash and debt does each share of Genelux have?

Each share of Genelux has $0.20 of cash and investments, as of June 30, 2026.

What is Genelux’s free cash flow per share?

−$0.70 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.

Has Genelux bought back shares?

Genelux’s share count rose about 308% from 2022 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.